Skip to main content
NIH funding notice RFA-AI-21-009

Mechanisms of HIV Resistance to Broadly Neutralizing Antibodies (bNAbs) (U01 Clinical Trial Not Allowed)

Closed on July 30, 2021.

Posted
March 30, 2021
Close date
July 30, 2021
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $4,555,806 in first-year total cost, median $1,504,603.

Most frequent study sections

  1. Special Emphasis Panel[ZAI1 VS-A (J1)]3

Most frequent institutions

  1. ROCKEFELLER UNIVERSITY1
  2. UNIVERSITY OF MINNESOTA1
  3. UNIVERSITY OF PENNSYLVANIA1
Competing awards under RFA-AI-21-009 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2022Defining the mechanisms of HIV resistance to bNAbs in humans1U01AI169385-01CASKEY, MARINAROCKEFELLER UNIVERSITY, NY$1,569,774ZAI1
2022Dissecting the mechanisms of HIV resistance in vivo to broadly neutralizing antibodies1U01AI169587-01ACHARYA, PRIYAMVADACRISPIN, MAXDEKOSKY, BRANDON JAMESHERSCHHORN, ALONUNIVERSITY OF MINNESOTA, MN$1,504,603ZAI1
2022Complementing broadly neutralizing antibodies and autologous responses to restrict virus escape and durably suppress HIV-11U01AI169767-01BAR, KATHARINE JUNELYNCH, REBECCA MARIEUNIVERSITY OF PENNSYLVANIA, PA$1,481,429ZAI1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-AI-21-009: Mechanisms of HIV Resistance to Broadly Neutralizing Antibodies (bNAbs) (U01 Clinical Trial Not Allowed) | ScienceDex | ConductScience